Impact on quality of life from multimodality treatment for lung cancer: a randomised controlled feasibility trial of surgery versus no surgery as part of multimodality treatment in potentially resectable stage III-N2 NSCLC (the PIONEER trial). (2021)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/bmjresp-2020-000846

PubMed Identifier: 34266853

Publication URI: http://europepmc.org/abstract/MED/34266853

Type: Journal Article/Review

Volume: 8

Parent Publication: BMJ open respiratory research

Issue: 1

ISSN: 2052-4439